SPDL1 and neoplasm: However, increased sPD-L1 levels were significantly associated with residual tumor burden (p = 0.022; Table 1; Figure 2) and reduced sPD-L2 levels were significantly (p = 0.0096) associated with platinum-resistance (Table 1; Figure 3).